Ichnos Sciences SA
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) (NCT05862012) | Ichnos Sciences SA | 2023-11-01 |
| Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma (NCT05427812) | Ichnos Sciences SA | 2022-09-27 |
| Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer (NCT03983395) | Ichnos Sciences SA | 2020-04-08 |
| Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma (NCT03309111) | Ichnos Sciences SA | 2017-10-25 |
Track Ichnos Sciences SA automatically
Every clearance here is in the API, with alerts when new ones post.